| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.003 |